At a glance
- Originator Purdue Frederick
- Class Antiasthmatics; Benzofurans
- Mechanism of Action Leukotriene B4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Allergic asthma
Most Recent Events
- 31 Aug 1998 No-Development-Reported for Allergic asthma in USA (Unknown route)
- 29 Aug 1996 New profile
- 29 Aug 1996 Preclinical development for Allergic asthma in USA (Unknown route)